Taglia Ilaria, Formichi Patrizia, Battisti Carla, Peppoloni Giulia, Barghigiani Melissa, Tessa Alessandra, Federico Antonio
Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy.
Molecular Medicine and Neurogenetics, IRCCS Stella Maris, Pisa, Italy.
J Cell Physiol. 2018 Mar;233(3):2324-2331. doi: 10.1002/jcp.26104. Epub 2017 Sep 18.
Primary familial brain calcification (PFBC) is an autosomal dominant rare disorder characterized by bilateral and symmetric brain calcifications, and neuropsychiatric manifestations. Four genes have been linked to PFBC: SLC20A2, PDGFRB, PDGFB, and XPR1. In this study, we report molecular and clinical data of a PFBC patient carrying a novel SLC20A2 mutation and we investigate the impact of the mutation on PiT-2 expression and function. Sanger sequencing of SLC20A2, PDGFRB, PDGFB, XPR1 led to the identification of a novel duplication of twelve nucleotides (c.1876_1887dup/ p.Trp626_Thr629dup) in SLC20A2 gene. SLC20A2 encodes for a cell membrane transporter (PiT-2) involved in maintenance of inorganic phosphate homeostasis. We performed an analysis of expression and functionality of PiT-2 protein in patient primary cultured fibroblasts. In patient fibroblasts, the mutation does not affect PiT-2 expression but alter sub-cellular localization. The Pi-uptake assay revealed a less Pi depletion in patient than in control fibroblasts, suggesting that SLC20A2 duplication may impair Pi internalization. This is the first study reporting sub-cellular expression analysis of mutant PiT-2 in primary cultured fibroblasts from a PFBC patient, showing that p.Trp626_Thr629dup in SLC20A2 alters PiT-2 sub-cellular localization and reduces Pi-uptake, leading to onset of PFBC in our patient.
原发性家族性脑钙化(PFBC)是一种常染色体显性罕见疾病,其特征为双侧对称性脑钙化及神经精神症状。已有四个基因与PFBC相关:SLC20A2、PDGFRB、PDGFB和XPR1。在本研究中,我们报告了一名携带新型SLC20A2突变的PFBC患者的分子和临床数据,并研究了该突变对PiT-2表达和功能的影响。对SLC20A2、PDGFRB、PDGFB、XPR1进行桑格测序,结果在SLC20A2基因中鉴定出一个12个核苷酸的新型重复(c.1876_1887dup/p.Trp626_Thr629dup)。SLC20A2编码一种参与维持无机磷酸盐稳态的细胞膜转运蛋白(PiT-2)。我们对患者原代培养的成纤维细胞中PiT-2蛋白的表达和功能进行了分析。在患者的成纤维细胞中,该突变不影响PiT-2的表达,但改变了亚细胞定位。Pi摄取试验显示,患者成纤维细胞中的Pi消耗低于对照成纤维细胞,这表明SLC20A2重复可能损害Pi的内化。这是第一项报道PFBC患者原代培养成纤维细胞中突变型PiT-2亚细胞表达分析的研究,表明SLC20A2中的p.Trp626_Thr629dup改变了PiT-2的亚细胞定位并降低了Pi摄取,导致我们的患者发病。